These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25694650)

  • 21. Infectious Diseases. Testing new Ebola tests.
    Vogel G
    Science; 2014 Sep; 345(6204):1549-50. PubMed ID: 25258059
    [No Abstract]   [Full Text] [Related]  

  • 22. Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study.
    Carnino L; Vetter P; Peyraud N; Aebischer-Perone S; Chappuis F; Huttner A; Kaiser L; Eperon G
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34128975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.
    Bolay FK; Grandits G; Lane HC; Kennedy SB; Johnson MP; Fallah MP; Wilson B; Njoh WS; McNay LA; Hensley LE; Higgs ES
    J Infect Dis; 2019 Apr; 219(10):1634-1641. PubMed ID: 30561672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
    Juan-Giner A; Tchaton M; Jemmy JP; Soumah A; Boum Y; Faga EM; Cisse M; Grais RF
    Vaccine; 2019 Nov; 37(48):7171-7177. PubMed ID: 30266489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.
    Huttner A; Agnandji ST; Combescure C; Fernandes JF; Bache EB; Kabwende L; Ndungu FM; Brosnahan J; Monath TP; Lemaître B; Grillet S; Botto M; Engler O; Portmann J; Siegrist D; Bejon P; Silvera P; Kremsner P; Siegrist CA; ; ;
    Lancet Infect Dis; 2018 Jul; 18(7):738-748. PubMed ID: 29627147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiplex real-time PCR method for rapid detection of Marburg virus and Ebola virus].
    Yang Y; Bai L; Hu KX; Yang ZH; Hu JP; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):313-5. PubMed ID: 23189855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ebola virus and Marburg virus].
    Morikawa S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():544-9. PubMed ID: 12718026
    [No Abstract]   [Full Text] [Related]  

  • 28. Where are the Ebola diagnostics from last time?
    Cnops L; De Smet B; Mbala-Kingebeni P; van Griensven J; Ahuka-Mundeke S; Ariën KK
    Nature; 2019 Jan; 565(7740):419-421. PubMed ID: 30670861
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic strategies for Ebola virus detection.
    Su S; Wong G; Qiu X; Kobinger G; Bi Y; Zhou J
    Lancet Infect Dis; 2016 Mar; 16(3):294-5. PubMed ID: 26973309
    [No Abstract]   [Full Text] [Related]  

  • 30. False-negative results of PCR assay with plasma of patients with severe viral hemorrhagic fever.
    Drosten C; Panning M; Guenther S; Schmitz H
    J Clin Microbiol; 2002 Nov; 40(11):4394-5. PubMed ID: 12409441
    [No Abstract]   [Full Text] [Related]  

  • 31. The evaluation of 7 commercial real-time PCR kits for Zaire ebolavirus using virus-like particle-encapsulated EBOV RNA.
    Wang G; Zhang R; Han Y; Chang L; Zhang D; Zhang L; Yang X; Liu C; Ding J; Zhang K; Lin G; Jiehong X; Li J
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):355-8. PubMed ID: 26431829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Signature Erosion in Ebola Virus Due to Genomic Drift and Its Impact on the Performance of Diagnostic Assays.
    Sozhamannan S; Holland MY; Hall AT; Negrón DA; Ivancich M; Koehler JW; Minogue TD; Campbell CE; Berger WJ; Christopher GW; Goodwin BG; Smith MA
    Viruses; 2015 Jun; 7(6):3130-54. PubMed ID: 26090727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomless infection with Ebola virus.
    Baxter AG
    Lancet; 2000 Jun; 355(9222):2178-9. PubMed ID: 10881884
    [No Abstract]   [Full Text] [Related]  

  • 34. Infectious diseases. The Ebola vaccine underdog.
    Link C; Cohen J
    Science; 2014 Oct; 346(6209):534. PubMed ID: 25359944
    [No Abstract]   [Full Text] [Related]  

  • 35. General introduction into the Ebola virus biology and disease.
    Zawilińska B; Kosz-Vnenchak M
    Folia Med Cracov; 2014; 54(3):57-65. PubMed ID: 25694096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-Time and End-Point PCR Diagnostics for Ebola Virus.
    Grolla A
    Methods Mol Biol; 2017; 1628():341-352. PubMed ID: 28573633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
    Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
    J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shedding of Ebola Virus in an Asymptomatic Pregnant Woman.
    Akerlund E; Prescott J; Tampellini L
    N Engl J Med; 2015 Jun; 372(25):2467-9. PubMed ID: 26083224
    [No Abstract]   [Full Text] [Related]  

  • 39. Containing Ebola at the Source with Ring Vaccination.
    Merler S; Ajelli M; Fumanelli L; Parlamento S; Pastore Y Piontti A; Dean NE; Putoto G; Carraro D; Longini IM; Halloran ME; Vespignani A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005093. PubMed ID: 27806049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan.
    Gibb TR; Norwood DA; Woollen N; Henchal EA
    J Clin Microbiol; 2001 Nov; 39(11):4125-30. PubMed ID: 11682540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.